Published: 2018-11-22

Articles

VALIDATION OF A PATIENT DECISION AID FOR CHOOSING BETWEEN DABIGATRAN AND WARFARIN FOR ATRIAL FIBRILLATION

Christina Hong, Shara Kim, Greg Curnew, Sam Schulman, Eleanor Pullenayegum, Anne Holbrook
Abstract 84 | PDF Downloads 48

Les Medicaments et la Sante Publique

sbryant sbryant
Abstract 57 | PDF Downloads 49

THERAPEUTIC DRUG MONITORING TO ASSESS CLINICAL RESPONSE TO SEDATIVE MEDICATIONS IN THE INTENSIVE CARE UNIT: A CASE REPORT AND DISCUSSION

Mahmoud Mosli, Daniel Ovakim, Rommel Tirona, George Dresser, Bandar Al-Judaibi
Abstract 90 | PDF Downloads 30

ODANACATIB DOES NOT INFLUENCE THE SINGLE DOSE PHARMACOKINETICS AND PHARMACODYNAMICS OF WARFARIN

S Aubrey Stoch, Rose Witter, David Hreniuk, Chengcheng Liu, Stefan Zajic, Anish Mehta, Patricia Chandler, Denise Morris, Hongwei Xue, Andrew Denker, John A Wagner
Abstract 114 | PDF Downloads 21

PHARMACOKINETICS IN REAL LIFE: SEX AND GENDER DIFFERENCES

Donald R Mattison
Abstract 180 | PDF Downloads 126

IMPACT OF PREGNANCY ON PHARMACOKINETICS OF MEDICATIONS

Mary F Hebert
Abstract 368 | PDF Downloads 161

GENDER BARRIERS IN POLICY AND REGULATION

Martha Nolan
Abstract 57 | PDF Downloads 27

CLINICAL PRACTICE GUIDELINE: CYP2D6 GENOTYPING FOR SAFE AND EFFICACIOUS CODEINE THERAPY

Parvaz Madadi, Ursula Amstutz, Michael Rieder, Shinya Ito, Vincent Fung, Soomi Hwang, Jacques Turgeon, Veronique Michaud, Gideon Koren, Bruce C Carleton
Abstract 323 | PDF Downloads 215

MULTIPLE PRESCRIBERS IN OLDER FREQUENT OPIOID USERS – DOES IT MEAN ABUSE?

C Ineke Neutel, Svetlana Skurtveit, Christian Berg, Solveig Sakshaug
Abstract 102 | PDF Downloads 33

PERSONALIZED BENEFIT-HARM INFORMATION INFLUENCES PATIENT DECISIONS REGARDING WARFARIN

Anne M Holbrook, Eleanor M Pullenayegum, Sue M Troyan, Milica Nikitovic, Mark A Crowther
Abstract 78 | PDF Downloads 19

COMA, METABOLIC ACIDOSIS, AND METHEMOGLOBINEMIA IN A PATIENT WITH ACETAMINOPHEN TOXICITY

Hussein D Kanji, Shazma Mithani, Paul Boucher, Valerian C Dias, Mark C Yarema
Abstract 139 | PDF Downloads 71

SENSORY CONTROL OF BALANCE: A COMPARISON OF CHILDREN WITH FETAL ALCOHOL SPECTRUM DISORDERS TO CHILDREN WITH TYPICAL DEVELOPMENT

Tracy L Jirikowic, Sarah W McCoy, Anat Lubetzky-Vilnai, Robert Price, Marcia A Ciol, Deborah Kartin, Lin-Ya Hsu, Beth Gendler, Susan J Astley
Abstract 75 | PDF Downloads 27

CLINICAL CORRELATES OF FETAL ALCOHOL SPECTRUM DISORDER AMONG DIAGNOSED INDIVIDUALS IN A RURAL DIAGNOSTIC CLINIC

Mansfield Mela, Audrey McFarlane, Tolulope T Sajobi, Hasu Rajani
Abstract 172 | PDF Downloads 66

PHARMACOKINETICS OF ETHANOL IN THE MATERNAL-FETAL UNIT

Irene Zelner, Gideon Koren
Abstract 116 | PDF Downloads 74

ALCOHOL EXPOSURE AMONG PREGNANT WOMEN IN SUB-SAHARAN AFRICA: A SYSTEMATIC REVIEW

Celia L Culley, Tasha D Ramsey, Godfrey Mugyenyi, Gertrude N Kiwanuka, Joseph Ngonzi, Stuart MacLeod, Gideon Koren, Brian E Grunau, Matthew O Wiens
Abstract 219 | PDF Downloads 78

IDENTIFYING THE NEUROBEHAVIORAL PHENOTYPE OF FETAL ALCOHOL SPECTRUM DISORDER IN YOUNG CHILDREN

Petra Breiner, Irena Nulman, Gideon Koren
Abstract 155 | PDF Downloads 66